Back to top
more

Bioanalytical Systems, Inc. (BASI)

(Delayed Data from NSDQ)

$2.08 USD

2.08
7,006

+0.08 (3.76%)

Updated May 3, 2019 03:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Medtronic (MDT) Directional Lead for DBS System Gets CE Mark

This SenSight system according to Medtronic (MDT), is set to enhance detection of local field potentials (LFPs).

Here's Why You Should Add Hologic (HOLX) to Your Portfolio

Investors remain optimistic about Hologic (HOLX) on its strong molecular diagnostic growth and robust international performance.

The Zacks Analyst Blog Highlights: Quest Diagnostics, LabCorp, InMode, Bioanalytical Systems and Semler Scientific

The Zacks Analyst Blog Highlights: Quest Diagnostics, LabCorp, InMode, Bioanalytical Systems and Semler Scientific

Urmimala Biswas headshot

Fed Eyes Faster Recovery in 2021: 3 MedTech Stocks to Buy

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

Investors are optimistic about IDEXX (IDXX) backed by robust CAG and LPD revenues growth and strong global performance boosting the top line.

Integra (IART) Neurosurgery Grows Sequentially Amid Supply Woe

Most of Integra's (IART) franchises or products succeed in sustaining the momentum after returning to growth in the third quarter.

AngioDynamics (ANGO) at a 52-Week High: What's Driving It?

AngioDynamics (ANGO) is optimistic about NanoKnife platform growth and the recent launch of Auryon Atherectomy.

Hologic (HOLX) Partners With Gallup on Women's Health Index

Hologic (HOLX) is working to develop a global women's health index through Gallup's World Poll to improve quality of life and life expectancy of women worldwide.

Abbott (ABT) Launches Telehealth Tool for Neuromodulation

Abbott (ABT) stated that Medicare will cover remote programming services as a telehealth benefit through the duration of the public health emergency.

QIAGEN (QGEN) Rides on Test Launches Amid COVID-19 Woes

QIAGEN (QGEN) expands specimen types that can be used on the existing NeuMoDx SARSCoV-2 test.

Hologic (HOLX) Boosts Diagnostics Portfolio With New Buyout

Hologic (HOLX) strengthens international capabilities and expands diagnostics arm across test menu, customer segments and geography with recent acquisition.